BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33721437)

  • 1. Correlation of Lgr5 expression with clinicopathological features of colorectal cancer and its diagnostic and prognostic values.
    Xu N; Gao K; Luo H; Wu Y; Shen B; Liu K
    J BUON; 2021; 26(1):87-92. PubMed ID: 33721437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
    Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers.
    Salehzadeh S; Hasanzad M; Kadijani AA; Akbari A
    J Gastrointest Cancer; 2020 Jun; 51(2):591-599. PubMed ID: 31422541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
    Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
    PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
    Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
    Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
    Wu XS; Xi HQ; Chen L
    World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
    Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Suga T; Ota H; Tanaka E
    Ann Diagn Pathol; 2019 Jun; 40():161-165. PubMed ID: 31100646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.
    Han Y; Xue X; Jiang M; Guo X; Li P; Liu F; Yuan B; Shen Y; Guo X; Zhi Q; Zhao H
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):267-73. PubMed ID: 25193236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lgr5 and CD44 expressions in different types of intestinal polyps and colorectal cancer].
    Chai N; Zhang W; Wang Y; Zhou Z; Zhang Y; Liu H; Wan J; Qin J; Wang S; Wang Y; Pei X; Wu B; Linghu E
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):972-6. PubMed ID: 23895835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
    Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
    Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
    Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
    Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with clinicopathological findings.
    Shekarriz R; Montazer F; Alizadeh-Navaei R
    Caspian J Intern Med; 2019; 10(4):412-416. PubMed ID: 31814939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.
    Hsu HC; Liu YS; Tseng KC; Hsu CL; Liang Y; Yang TS; Chen JS; Tang RP; Chen SJ; Chen HC
    Int J Colorectal Dis; 2013 Nov; 28(11):1535-46. PubMed ID: 23784051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.